- Home
- Publications
- Publication Search
- Publication Details
Title
B7-H3/CD276: An Emerging Cancer Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-19
DOI
10.3389/fimmu.2021.701006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration
- (2021) Xiaomao Hu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance
- (2021) Cheng Wang et al. Cell Stem Cell
- A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3–Specific CAR T Cells in Solid Tumors
- (2021) Xinyuan Lei et al. CLINICAL CANCER RESEARCH
- Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
- (2021) Alexandre el Hage et al. Cancers
- Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
- (2020) Jackson G. Egen et al. IMMUNITY
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression
- (2020) Ruoqin Wang et al. Cell Death & Disease
- Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
- (2020) Johanna Theruvath et al. NATURE MEDICINE
- Silencing of CD276 suppresses lung cancer progression by regulating integrin signaling
- (2020) Fang Li et al. Journal of Thoracic Disease
- Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity
- (2020) Yao Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer
- (2020) Shuo Yang et al. Frontiers in Pharmacology
- B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role
- (2020) Ian J. Purvis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo
- (2020) Daniel A. Vallera et al. Cancers
- B7-H3 targeted antibody-based immunotherapy of malignant diseases
- (2020) Theodoros Michelakos et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Adjuvant therapy following induction therapy and surgery improves survival in N2‐positive non–small cell lung cancer
- (2020) Abby A. White et al. JOURNAL OF SURGICAL ONCOLOGY
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- Small-Molecule Immuno-Oncology Therapy: Advances, Challenges and New Directions
- (2019) Shulun Chen et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density
- (2019) Phyu P Aung et al. CLINICAL CANCER RESEARCH
- Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy
- (2019) Yasunori Minami et al. EUROPEAN RADIOLOGY
- B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
- (2019) Tongguo Shi et al. Cell Death & Disease
- p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
- (2019) Karine Flem-Karlsen et al. Scientific Reports
- B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
- (2019) Dean Nehama et al. EBioMedicine
- Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis
- (2019) Ian J. Purvis et al. Journal of Clinical Medicine
- Investigation of uniform sized multicellular spheroids raised by microwell arrays after the combined treatment of electric field and anti-cancer drug
- (2019) Kin Fong Lei et al. BIOMEDICAL MICRODEVICES
- Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
- (2019) Dongli Cai et al. Cellular & Molecular Immunology
- IL-15/B7-H3 TriKEs-Based Immunotherapy for Pancreatic Ductal Adenocarcinoma
- (2019) Filippos Kontos et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meningioma
- (2019) Jiaojiao Deng et al. World Neurosurgery
- High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation
- (2019) Heather L. MacGregor et al. Journal for ImmunoTherapy of Cancer
- B7-H3 in tumors: friend or foe for tumor immunity?
- (2018) Gen Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma
- (2018) Vinod Varki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
- (2018) Kimio Yonesaka et al. CLINICAL CANCER RESEARCH
- Unraveling the Mechanisms of Manual Therapy: Modeling an Approach
- (2018) Joel E. Bialosky et al. JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY
- Abstract 820: Preclinical development of MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer
- (2018) Juniper A. Scribner et al. CANCER RESEARCH
- Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma
- (2018) Dustin Proctor et al. OncoImmunology
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
- (2017) T Girardi et al. LEUKEMIA
- Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells
- (2017) Karine Flem-Karlsen et al. Pigment Cell & Melanoma Research
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
- (2017) Zachary B. Davis et al. SEMINARS IN IMMUNOLOGY
- Expression of CD24 and B7-H3 in breast cancer and the clinical significance
- (2017) Fang Cong et al. Oncology Letters
- B7-H3 promotes gastric cancer cell migration and invasion
- (2017) Yecheng Li et al. Oncotarget
- Spectroscopic Photoacoustic Molecular Imaging of Breast Cancer using a B7-H3-targeted ICG Contrast Agent
- (2017) Katheryne E. Wilson et al. Theranostics
- B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway
- (2017) Yuchao Li et al. Journal of Cancer
- Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α
- (2016) Sangbin Lim et al. CANCER RESEARCH
- Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
- (2016) E. Picarda et al. CLINICAL CANCER RESEARCH
- The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma
- (2016) Ling Wang et al. TUMOR BIOLOGY
- The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer
- (2016) Bo Jiang et al. Oncotarget
- B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
- (2016) Juan Ma et al. Oncotarget
- Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors
- (2016) Caroline E. Nunes-Xavier et al. Oncotarget
- Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway
- (2016) Chao Xie et al. Scientific Reports
- Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3
- (2015) Mahiuddin Ahmed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Big opportunities for small molecules in immuno-oncology
- (2015) Jerry L. Adams et al. NATURE REVIEWS DRUG DISCOVERY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma
- (2015) Ling Wang et al. TUMOR BIOLOGY
- Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3
- (2015) Ting Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells
- (2015) Wei Zhang et al. OncoTargets and Therapy
- Differential expression of 2IgB7-H3 and 4IgB7-H3 in cancer cell lines and glioma tissues
- (2015) ZHENXIN WANG et al. Oncology Letters
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway
- (2014) Xiaoyu Wu et al. MEDICAL ONCOLOGY
- EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway
- (2014) Hongli Li et al. MEDICAL ONCOLOGY
- Tumor-Antigen–Binding Bispecific Antibodies for Cancer Treatment
- (2014) Ulrich H. Weidle et al. SEMINARS IN ONCOLOGY
- RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway
- (2014) Huiyan Niu et al. TUMOR BIOLOGY
- Molecular Basis of NF-κB Signaling
- (2013) Johanna Napetschnig et al. Annual Review of Biophysics
- Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma
- (2013) Weiwei Chen et al. PLoS One
- Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
- (2013) Vladimir Vigdorovich et al. STRUCTURE
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation
- (2011) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
- B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis
- (2010) Takaaki Arigami et al. ANNALS OF SURGERY
- B7-H3 and Its Role in Antitumor Immunity
- (2010) Martin Loos et al. Clinical & Developmental Immunology
- Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
- (2010) Xingxing Zang et al. MODERN PATHOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Apoptosis and colorectal cancer: implications for therapy
- (2009) Shi Yu Yang et al. TRENDS IN MOLECULAR MEDICINE
- Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum
- (2008) Guangbo Zhang et al. IMMUNOLOGY
- Correction for Hashiguchi et al., Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses
- (2008) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The contrasting role of B7-H3
- (2008) K. A. Hofmeyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now